A Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of CLF065 in the Treatment of Chronic Pouchitis
Latest Information Update: 13 Nov 2025
At a glance
- Drugs CLF-065 (Primary)
- Indications Pouchitis
- Focus Therapeutic Use
- Acronyms OPUS
Most Recent Events
- 13 Nov 2025 New trial record